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Introduction:
With an annual incidence of 10-40 per 100,000 person years and a mortality between 7% -33% 1, 2, 3 status epilepticus (SE) is one of the most frequent neurological emergencies. Several independent predictors of poor outcome have been identified, including advanced age, de novo presentation, impairment of consciousness before treatment, and seizure type, but the most critical factor by far is the underlying etiology 4, 5, 6, 7 . Although much attention has been paid to seizure cessation with administration of anti-seizure drugs (ASDs) 8, 9 , it is far more critical to rapidly identify and target a treatable underlying etiology 9 . Indeed, some etiologies such as cerebrovascular events, severe metabolic disturbances, alcohol withdrawal or intoxication, brain tumor related events and infections need emergent and specific treatments beyond ASDs. Earlier identification of the SE etiology would enhance rapid and more focused treatment, and potentially improve outcome.
Due to the diversity of possible etiology 10 , this is potentially a puzzling process in acute and emergent situation for a clinician unfamiliar with SE, particularly outside of a tertiary care facility. Clinical decision supporting tools may help clinicians to gather important data for the decision-making process, and guide medical management more effectively, thus reducing practice errors and costs 11 . These tools are widely available in many other clinical settings, and notably for other acute conditions for which rapid identification of the underlying etiology is fundamental, such as chest pain 12 or acute headache 13 .
In order to assist a clinician to rapidly identify an underlying etiology, we developed a user-friendly tool labeled Status Epilepticus Etiology Identification Tool (SEEIT)
utilizing elements of the clinical history and routinely available laboratory investigations that can be used at the bedside in the Emergency Department (ED) or the intensive care unit (ICU) to streamline the evaluation into etiology. We performed a multi-center prospective observational study in order to determine the validity and reliability of this tool.
Methods:
• Primary research question:
The primary research question was to evaluate the validity and reliability of the SEEIT by assessing its propensity to identify the correct etiology and its interrater agreement.
• Standard Protocol Approvals, Registrations, and Patient Consents:
The Institutional Review Boards of each center approved this study. As this observational study involved no risk for patients and focused on acute phase of critically ill patients, consent was waived.
• Cohort and SE definition:
In this observational study, we prospectively identified every consecutive adult patient (age >16 years) with SE admitted to four university hospitals, from to an adequate dose of an initial benzodiazepine followed by a second-line of a non-sedating ASD 9 . The end of the SE episode was defined by the last clinical or electrical seizure without recurrence for at least 48 hours, off sedation.
The etiology of each SE episode was described in free text based on medical charts and then assigned to the nineteen categories listed in Table 1 .
Outcome at discharge was categorized as return to pre-morbid baseline, new morbidity or death.
•
Status Epilepticus Etiology Identification Tool (SEEIT) description and evaluation
The proposed tool, shown in Figure 1 , was developed by two of the authors (VA and AOR) based on the list of the potential underlying etiology included in the current SE guidelines 9 and adapted based on their clinical experience.
After its completion, it was reviewed by two others authors, experts in the field (JWL and FWD). Hypertensive encephalopathy was not included in the tool:
since hypertension is frequently seen secondary to the acute brain injury, too much emphasis on hypertension in the acute setting could be misleading.
Moreover hypertensive encephalopathy is not a frequent cause of SE 10, 17 .
The tool is designed as a checklist including 4 main parts and several subsequent questions. The first part aims to confirm the diagnosis of SE (fulfilling the operational definition) 18 and also raises the question of psychogenic non-epileptic status epilepticus (PNESE), which can be mistaken for refractory SE 19 . The tool then discriminates between SE in the setting of known epilepsy or a structural brain disorder vs. occurring without any known brain pathology. For each of these parts, the tool includes questions about common treatable etiologies. Finally, the fourth part emphasizes signs suggestive of a CNS infection and includes cerebrospinal fluid (CSF) findings if a lumbar puncture is performed. At the end of the assessment, the rater is invited to record the suspected etiology as free text based on the assessment directed by the SEEIT. The tool also includes the list of investigations required by current guidelines for SE evaluation 9 . The etiology is eventually placed into one of the 19 categories (see Table 1 ) to enable evaluating concordance with the definitive etiology determined at the end of the hospital stay. Of note, for the concordance evaluation, when an acute precipitating factor occurred in the context of a remote brain injury, the "acute" condition was considered predominant, as the tool aims to identify acute treatable conditions.
The SEEIT was completed for every patient at the time of identification by the study team --based only on the information available in the ED or at the time of in-hospital SE identification and before discharge summary diagnosis was available. The first author (VA) completed the SEEIT for the three centers involved in Boston, USA (BWH, MGH, BIDMC) and the EEG attending filled the assessment under the same conditions for the patients in the CHUV, Lausanne, Switzerland.
Because the SEEIT was designed to be used by non-specialist physicians and was also completed by neurologists with specialty training in epilepsy, an inter-rater evaluation between one of the investigators (VA) and an emergency physician (fourth year Emergency resident at BWH) (DC) was performed for the first 30 cases of SE treated at BWH. To reflect the "real-life" use of the tool, the ED physician did not receive any training in use of the SEEIT.
Statistical analysis
Inter-rater evaluation between VA and DC, and concordance between the etiologies generated by the SEEIT and the etiology finally determined during the hospitalization, were evaluated with Cohen's kappa coefficient. In order to identify any misleading factors for correct early etiology identification, patients with correct and incorrect etiologies generated using the SEEIT were compared using χ 2 , ANOVA and Wilcoxon rank-sum test, as required.
Significance was assumed with p < 0.05. Data were analyzed using Stata 11.1 (StataCorp, College Station, Texas, USA).
Results:
The Figure 2 outlines the study profile. A total of 212 consecutive patients were included in the study. Demographics and SE characteristics are summarized in Table   2 . Gender was evenly distributed; the median age was 60 years old (range: 18-93).
Premorbid seizures occurred in 49.1% patients. About half of the subjects had generalized convulsive seizures, followed by 28.9% with focal seizures with consciousness impairment, 15% with focal seizures without impairment of consciousness, and 8% with NCSEC. Absence and myoclonic status were infrequent, 1.42% and 0.5% respectively. Consciousness was impaired in most, with 17% of patients presenting as "comatose" and 41.5% "stuporous". The mean STESS was 2.64 (SD: 1.63) and around half of patients suffered from refractory SE. A median of 3 ASDs (range: 0-13) was used and 11.3% underwent intubation as part of a SE treatment protocol. The mortality rate was 12.8%, while 45.3% of patients returned to their premorbid clinical baseline at discharge.
In addition to the 212 patients in SE, two had EEGs for SE but were eventually found to have PNESE. Both were treated acutely as refractory SE. One was intubated for "convulsion control." Of note, in the patients' charts, there were descriptions of the events including features such as "waxing-and-waning" symptoms "stopped by suggestion" for the first patient; and "waxing and waning" and "pelvic thrusting movements" for the second. The SEEIT-generated etiology was correct for these two events.
The definitive etiologies at hospital discharge are listed in 
. Table 3 provides a detailed description of the 24 cases in which the etiology generated using the tool was incorrect. Seven (29.2%) were misdiagnosed due to information missed on early imaging, five (20.8%) due to CSF misinterpretation, three (12.5%) to incomplete history, and three (12.5%) presentations were probably too complex to be diagnosed accurately in the ED setting (1 NMDA-encephalitis, one with microangiopathic hemolytic anemia, and one with toxoplasmosis). In two patients (8.4%), known remote conditions were incorrectly assumed to be the etiology when others factors were actually responsible. One misdiagnosis (4.2%) was due to misinterpretation of a systemic inflammatory response syndrome (SIRS).
Finally, three (12.5 %) were misdiagnosed due to disagreement on causality judgment of minor precipitants between the tool rater and the hospital discharge summary.
Discussion:
The principal finding of this study is that early identification of the underlying etiology for SE is possible using a tool designed to guide differential diagnosis assessment.
The SEEIT appears valid, with concordance in 88.7% of cases between the etiology hypothesis generated using SEEIT and the definitive etiology determined at hospital discharge. It is also reliable, with a high inter-rater agreement between physicians of different subspecialties and levels (ED resident and trained neurologist).
Consequently, the SEEIT may be of assistance to non-specialist physicians in guiding their identification of the etiology of SE promptly and expeditiously. A further relevant finding is that two patients presenting with PNESE signs noted in the first part of the SEEIT were treated as having refractory SE, possibly because of lack of awareness of PNESE symptoms in the ED; one was even intubated. Indeed, these episodes are frequently misdiagnosed as "refractory SE" 19 and poor outcome due to overtreatment has been reported 26 . By highlighting some clinical features of PNESE, the SEEIT may help avoid unnecessary, and potentially harmful, treatment in these occasions. Of note, the rate of PNESE mistaken for SE is low in this cohort. This is likely explained by the tertiary care setting and the 24/7 availability of neurology consultants in the four centers involved in this study.
We were unable to demonstrate any significant factors that interfered with correct etiology identification using our tool, other than presence of prior seizures. This may reflect the fact that medication non-adherence or recent treatment adjustments are common SE causes and are easy to recognize. This reinforces the principle that all patients with SE should be evaluated carefully to identify the underlying etiology, independently of age, seizure type, or SE severity.
The detailed description of misdiagnosed cases (Table 3) shows that brain MRI is crucial if history and CT scan fail to identify the etiology; in another smaller study, MRI improved the diagnosis by 32% in a cohort of 34 patients 27 . CSF data may be misleading. Some cases of SE were incorrectly labeled as due to infectious processes because of the CSF pleocytosis --which turned out to be non-infectious (due to neoplasic or auto-immune conditions) or due to the SE itself in one case of mild pleocytosis, which can be seen in 10% of SE occurring in the setting of a known epilepsy 28 . Nevertheless, because the exact cause of CSF pleocytosis may take several days to be clarified, and in view of the potential poor outcome associated with CNS infections, it is still reasonable to consider all SE with pleocytosis as infectious until proven otherwise. This study also included a 75-year-old man with new onset refractory SE associated with fever and a normal CSF study (4 white cells) performed 36 hours after symptom onset his and CSF PCR showed HSV 1 encephalitis. CSF is abnormal in 95% of HSV1 encephalitis 29 , but can be normal early in the illness 30 , as illustrated by this case. This particular pitfall is pointed out in the SEEIT tool.
As reported earlier 31, 32 , subtherapeutic ASD levels due to non-adherence or treatment adjustment are among the most frequent causes of SE. This should be addressed carefully by a thorough history, and ASD levels should be obtained when appropriate. Because some newer ASD levels cannot be measured quickly, detecting non-adherence based on this feature alone can be difficult. A careful history with relatives is thus very important in such cases. The relatively high incidence of SE due to brain tumors in this cohort, as opposed to previous studies 31, 33 is likely due to a referral bias, as the four institutions in this study have, or are closely associated with, large neuro-oncology clinics. Similarly, while alcohol withdrawal was a frequent precipitant in other series, ranging from 13% 32 to 17% 31 it was infrequent in ours (2.8%), also probably explained by a referral bias.
The strength of this study is the large number of patients from four international sites and the prospective evaluation implying a good potential for generalization and good data quality. The main limitation is that the SEEIT was completed by the study investigator familiar with it (a neurologist) and not by the treating physician. This could help to explain the high concordance coefficient between the SEEIT and the etiology determined after a comprehensive evaluation. Still, the inter-rater agreement evaluation between the study investigator and an emergency physician was high, and there was no difference in the agreement rate among the four centers involved.
Another limitation is that the SEEIT relies on history for some items and sometimes there are neither relatives nor witnesses. A comprehensive history is a key component in the management of many conditions, including SE, and unfortunately, our tool cannot fill the lack of information in these situations. Moreover, as patients were screened by using the EEG request (and not in the ED), we could not exclude the possibility that some information available in the EEG laboratory influenced the investigator completing the tool, but only information available during the ED stay was used for the early etiology assessment. Also, we cannot exclude that due to the EEG screening process, some brief or unrecognized SE episodes were missed.
Indeed, in these situations, treating physician might not have requested an EEG.
Also, the yield of each item in the SEEIT was not evaluated, but in clinical practice, a diagnosis is made after a global assessment and not based on one particular feature alone. Another shortcoming is that the SEEIT failed to identify definite etiology correctly because sometimes history, imaging or some data were not available. The results would perhaps have been different if all information were available in each case. However, in that case, this would probably have increased the performance of SEEIT. The tertiary hospital setting may also confer a selection bias. Indeed, this may have resulted in the inclusion of more patients with severe SE. We do not believe that this should influence the validity of the SEEIT. Moreover, fewer patients were enrolled at the MGH than at the BWH. We cannot exclude the possibility of under sampling at the MGH and do not expect this to have influenced our findings.
Finally, we used broad inclusion criteria: all types of SE, and an operational definition 9 , as opposed to more rigorous inclusion criteria focusing on generalized convulsive SE lasting more than 30 minutes. As the SEEIT is designed to be used in daily practice, these inclusion criteria may better reflect "actual clinical practice".
This study shows that the SEEIT correctly identify the cause of a SE in 88.7%. It also demonstrates that it is possible to identify the etiology of an episode of SE early with a valid and reliable clinical tool to guide differential diagnosis, used by physicians from different subspecialties. Further studies are needed to evaluate whether the SEEIT will improve decision-making process in SE management, avoiding unnecessary investigations or treatments, influencing the length of stay, or impacting on clinical outcome.
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The SE in the context of sepsis (pulmonary origin) and known epilepsy. So, using the SEEIT, sepsis was considered as a provocative factor. Later MRI was consistent with a PRES. However it was not excluded for certain that the MRI changes were due to seizures.
Etiology missed on CT 12 40 F Yes Sepsis Known epilepsy without provocative factors SE in the context of fever, systemic inflammatory response syndrome (SIRS) and known epilepsy. So, using the SEEIT, sepsis was considered as a provocative factor. The complete evaluation did not find any infectious source. The SIRS was attributed to the SE itself.
SIRS incorrectly suspected
The previous history of subarachnoid hemorrhage was unknown at initial presentation. Presented with flu-like symptoms a week before entering a prolonged refractory non-convulsive SE in coma. The CSF in early phase showed a mild lymphocytosis (15 white blood cells / mm3). Despite a very broad evaluation including wide infectious and autoimmune panels, no etiology was found. She left the hospital 74 days later with significant cognitive problems.
Incomplete history information

CSF data misinterpreted
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Figure 1: The Status Epilepticus Etiology Identification Tool (SEEIT)
Legend: The SEEIT tool as been designed to guide SE etiology assessment. It has to be used along with anti-seizure-drug protocol. Each point has to be assessed. 
